Logo image of CBAT

CBAK ENERGY TECHNOLOGY INC (CBAT) Stock Fundamental Analysis

USA - NASDAQ:CBAT - US14986C1027 - Common Stock

0.9 USD
-0.02 (-2.17%)
Last: 11/4/2025, 1:41:47 PM
Fundamental Rating

3

Taking everything into account, CBAT scores 3 out of 10 in our fundamental rating. CBAT was compared to 92 industry peers in the Electrical Equipment industry. CBAT may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CBAT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CBAT had negative earnings in the past year.
CBAT had a positive operating cash flow in the past year.
In multiple years CBAT reported negative net income over the last 5 years.
In multiple years CBAT reported negative operating cash flow during the last 5 years.
CBAT Yearly Net Income VS EBIT VS OCF VS FCFCBAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

CBAT's Return On Assets of -2.75% is fine compared to the rest of the industry. CBAT outperforms 61.96% of its industry peers.
CBAT has a better Return On Equity (-7.74%) than 63.04% of its industry peers.
Industry RankSector Rank
ROA -2.75%
ROE -7.74%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
CBAT Yearly ROA, ROE, ROICCBAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

CBAT's Profit Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 17.22%, CBAT is doing worse than 63.04% of the companies in the same industry.
In the last couple of years the Gross Margin of CBAT has grown nicely.
The Profit Margin and Operating Margin are not available for CBAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
CBAT Yearly Profit, Operating, Gross MarginsCBAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

3

2. Health

2.1 Basic Checks

CBAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CBAT remains at a similar level compared to 1 year ago.
The number of shares outstanding for CBAT has been increased compared to 5 years ago.
Compared to 1 year ago, CBAT has an improved debt to assets ratio.
CBAT Yearly Shares OutstandingCBAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CBAT Yearly Total Debt VS Total AssetsCBAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CBAT has an Altman-Z score of -0.15. This is a bad value and indicates that CBAT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CBAT (-0.15) is comparable to the rest of the industry.
CBAT has a debt to FCF ratio of 17.02. This is a negative value and a sign of low solvency as CBAT would need 17.02 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 17.02, CBAT is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
CBAT has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CBAT (0.33) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 17.02
Altman-Z -0.15
ROIC/WACCN/A
WACC5.8%
CBAT Yearly LT Debt VS Equity VS FCFCBAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 0.72 indicates that CBAT may have some problems paying its short term obligations.
The Current ratio of CBAT (0.72) is worse than 82.61% of its industry peers.
CBAT has a Quick Ratio of 0.72. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
CBAT's Quick ratio of 0.53 is on the low side compared to the rest of the industry. CBAT is outperformed by 79.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.53
CBAT Yearly Current Assets VS Current LiabilitesCBAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

CBAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -158.82%.
Measured over the past years, CBAT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -42.83% on average per year.
The Revenue for CBAT has decreased by -35.70% in the past year. This is quite bad
CBAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.40% yearly.
EPS 1Y (TTM)-158.82%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%-142.86%
Revenue 1Y (TTM)-35.7%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%-15.21%

3.2 Future

Based on estimates for the next years, CBAT will show a very negative growth in Earnings Per Share. The EPS will decrease by -20.77% on average per year.
The Revenue is expected to grow by 11.65% on average over the next years. This is quite good.
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-22.1%
Revenue Next 2Y11.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CBAT Yearly Revenue VS EstimatesCBAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
CBAT Yearly EPS VS EstimatesCBAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.1 -0.1

3

4. Valuation

4.1 Price/Earnings Ratio

CBAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CBAT is valuated reasonably with a Price/Forward Earnings ratio of 11.03.
92.39% of the companies in the same industry are more expensive than CBAT, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CBAT to the average of the S&P500 Index (22.53), we can say CBAT is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 11.03
CBAT Price Earnings VS Forward Price EarningsCBAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

CBAT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CBAT is cheaper than 77.17% of the companies in the same industry.
Industry RankSector Rank
P/FCF 34.74
EV/EBITDA N/A
CBAT Per share dataCBAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A cheap valuation may be justified as CBAT's earnings are expected to decrease with -20.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.77%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CBAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (11/4/2025, 1:41:47 PM)

0.9

-0.02 (-2.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-18 2025-08-18/bmo
Earnings (Next)11-07 2025-11-07/bmo
Inst Owners2.19%
Inst Owner Change-0.61%
Ins Owners25.81%
Ins Owner Change0%
Market Cap79.78M
Revenue(TTM)145.46M
Net Income(TTM)-9144000
Analysts0
Price Target1.53 (70%)
Short Float %0.46%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.97%
Min Revenue beat(2)-34.33%
Max Revenue beat(2)18.4%
Revenue beat(4)1
Avg Revenue beat(4)-22.71%
Min Revenue beat(4)-50.36%
Max Revenue beat(4)18.4%
Revenue beat(8)2
Avg Revenue beat(8)-15.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)13.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)11.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.03
P/S 0.55
P/FCF 34.74
P/OCF 2.38
P/B 0.67
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)0.08
Fwd EY9.07%
FCF(TTM)0.03
FCFY2.88%
OCF(TTM)0.38
OCFY41.94%
SpS1.64
BVpS1.33
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.75%
ROE -7.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.22%
FCFM 1.58%
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 17.02
Debt/EBITDA N/A
Cap/Depr 425.27%
Cap/Sales 21.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.53
Altman-Z -0.15
F-Score2
WACC5.8%
ROIC/WACCN/A
Cap/Depr(3y)245.38%
Cap/Depr(5y)296.85%
Cap/Sales(3y)10.68%
Cap/Sales(5y)16.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-158.82%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%-142.86%
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.7%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%-15.21%
Revenue Next Year-22.1%
Revenue Next 2Y11.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-128.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y118.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y146.05%
OCF growth 3YN/A
OCF growth 5YN/A

CBAK ENERGY TECHNOLOGY INC / CBAT FAQ

What is the fundamental rating for CBAT stock?

ChartMill assigns a fundamental rating of 3 / 10 to CBAT.


Can you provide the valuation status for CBAK ENERGY TECHNOLOGY INC?

ChartMill assigns a valuation rating of 3 / 10 to CBAK ENERGY TECHNOLOGY INC (CBAT). This can be considered as Overvalued.


How profitable is CBAK ENERGY TECHNOLOGY INC (CBAT) stock?

CBAK ENERGY TECHNOLOGY INC (CBAT) has a profitability rating of 2 / 10.